CELEX: 62013CB0006
Language: en
Date: 2013-11-07 00:00:00
Title: Case C-6/13 P: Order of the Court (Tenth Chamber) of 7 November 2013 — IDT Biologika GmbH v European Commission (Appeal — Article 181 of the Rules of Procedure of the Court — Public supply contracts — Call for tenders related to the supply in Serbia of rabies vaccines — Rejection of a tender — Appeal clearly inadmissible or unfounded)

21.12.2013   
            
            
               EN
            
            
               Official Journal of the European Union
            
            
               C 377/4
            
         Order of the Court (Tenth Chamber) of 7 November 2013 — IDT Biologika GmbH v European Commission
   (Case C-6/13 P) (1)
   
   (Appeal - Article 181 of the Rules of Procedure of the Court - Public supply contracts - Call for tenders related to the supply in Serbia of rabies vaccines - Rejection of a tender - Appeal clearly inadmissible or unfounded)
   2013/C 377/07
   Language of the case: German
   
      Parties
   
   
      Appellant: IDT Biologika GmbH (represented by: R. Gross and T. Kroupa, Rechtsanwälte)
   
      Other party to the proceedings: European Commission (represented by: F. Erlbacher and T. Scharf, acting as Agents)
   
      Re:
   
   Appeal brought against the judgment of the General Court (Second Chamber) of 25 October 2012 in Case T-503/10 IDT Biologika v Commission by which the General Court dismissed an application for annulment of the decision of the Delegation of the European Union to the Republic of Serbia of 10 August 2010 awarding the contract (reference EuropeAid/129809/C/SUP/RS) for the supply of rabies vaccines for vaccination campaigns in Serbia to the consortium led by the company Bioveta a.s. and rejecting the tender submitted by the applicant — Whether the limits to which the Commission is subject in the exercise of its discretion were exceeded
   
      Operative part of the order
   
   
               1.
            
            
               The appeal is dismissed.
            
         
               2.
            
            
               IDT Biologika GmbH is ordered to pay the costs.
            
         
      (1)  OJ C 108, 13.4.2013.